Medium Biosciences (YC S21) — AI-designed affinity reagents
We turn advances in AI and protein design into experimentally validated molecular tools, partnering with research teams and diagnostic developers to deliver high-performance affinity reagents in weeks, not months.
Medium Biosciences is a Y Combinator company in the Summer 2021 batch. Its directory entry describes it as: AI-designed Affinity Reagents. The founder listed is Mohamed Hassan Kane (Founder) (Y Combinator directory entry, August 26, 2021).
Get an email when Medium Biosciences changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
We turn advances in AI and protein design into experimentally validated molecular tools, partnering with research teams and diagnostic developers to deliver high-performance affinity reagents in weeks, not months.
Checked away from the directory entry. What is below does not come from the company's Y Combinator page.
Custom affinity reagents, designed for your target and application. Medium Biosciences designs experimentally validated affinity reagents in weeks, not months.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Mohamed Hassan Kane
Founder
Studied CS & AI at MIT. Published 8 papers across LLMs, computer vision, and protein design. Now: AI & protein design → reagents
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
One of 58 companies held here in Healthcare › Diagnostics.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Want the whole picture on Medium Biosciences?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Medium Biosciences: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Medium Biosciences covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Medium Biosciences: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
